Wednesday, April 8, 2009




Radiosurgery, also known as stereotactic radiotherapy, (SRS) is a medical procedure which allows non-invasive treatment of benign and malignant conditions, arteriovenous malformations (AVM's), and some functional disorders by means of directed beams of ionizing radiation. It is a relatively recent technique (1951), which is used to ablate, by means of a precise dosage of radiation, intracranial and extracranial tumors and other lesions that could be otherwise inaccessible or inadequate for open surgery. There are many nervous diseases for which conventional surgical treatment is difficult or has many deleterious consequences for the patient, due to arteries, nerves, and other vital structures being damaged.

Definition and applications

Radiation oncologists make use of highly sophisticated, highly precise and complex instruments, such as stereotactic devices, linear accelerators, gamma knife, computers and laser beams. The highly precise irradiation of targets within the brain is planned by the radiation oncologist based on images, such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography of the brain and body. The radiation is applied from an external source, under precise mechanical orientation by a specialized apparatus. Multiple beams are directed (collimated) and centered at the intracranial or extracranial lesion to be treated. In this way, healthy tissues around the target are relatively spared.

Patients can be treated within one to five days and as an outpatient. By comparison, the average hospital stay for a craniotomy (conventional neurosurgery, requiring the opening of the skull) is about 15 days. Radiosurgery costs less than conventional surgery, and with much less morbidity, e.g. mortality, pain and post-surgical complications, such as hemorrhage and infection. The period of recovery is minimal, and in the day following the treatment the patient may return to his or her normal life style, without any discomfort. The major disadvantage of radiosurgery in relation to open surgery is the duration of time required to achieve the desired effects, while its non-invasive character is perhaps its major advantage.


Radiosurgery was first developed at the Karolinska Institute of Stockholm, Sweden in 1949. It was jointly developed by Dr. Lars Leksell, a neurosurgeon and Bjorn Larsson, a radiobiologist from Uppsala University. Leksell initially used protons from a cyclotron to irradiate brain tumor lesions.

In 1968, they developed the Gamma Knife, a new device exclusively for radiosurgery, which consisted of radioactive sources of Cobalt-60 placed in a kind of helmet with central channels for irradiation, using gamma rays. In the latest version of this device, 192 sources of radioactive cobalt direct gamma radiation to the center of a helmet, where the patient's head is inserted. This is called the Leksell Gamma Knife Perfexion.

In order to achieve a high degree of precision, the patient's head is placed on a rigid frame of reference called a stereotactic frame that is inserted into a metal helmet.

A linear accelerator (LINAC) may also be used to deliver radiosurgery. LINAC based radiosurgery was pioneered at the University of Florida College of Medicine and introduced by Betti and Colombo in the mid 1980's. High energy, narrowly focused beams of x-rays are employed.

This system differs from the Gamma Knife in a variety of ways. The Gamma Knife produces gamma rays from the decay of Co-60 of an average energy of 1.25 MeV. A LINAC produces x-rays from the impact of accelerated electrons striking a high z target (usually tungsten). A LINAC therefore can generate any number of energy x-rays, though usually 6 MV photons are used. The Gamma Knife has over ~200 sources arrayed in the helmet to deliver a variety of treatment angles. On a LINAC the gantry must move in space to change the delivery angle. Both can move the patient in space to also change the delivery point. Both devices use a stereotactic frame to restrict the patient's movement.

At some medical centers such as in Boston and in California, particle accelerators built for doing research in high energy physics have been used since the 1960's for the treatment of brain tumors and arteriovenous malformations of the brain in humans.

Several generations of the frameless robotic Cyberknife system have been developed since its initial inception in 1990. It was invented by John R. Adler, a Stanford University Professor of Neurosurgery and Radiation Oncology and is sold by the Accuray company, located in Sunnyvale, California.

Hence three of the latest radiosurgery treatments available in 2009 are the CyberKnife and Gamma Knife systems and the Stereotactic Linear Accelerator with Image Guided Radiotherapy, Respiratory Gating, Cone beam CT, Kv Imaging and RapidArc.[1]

Stereotactic radiosurgery can successfully treat many different types of tumors, both benign and malignant. The malignant brain tumors treated most often are the "brain metastases" or tumors that have spread to the brain.[2] A study in 2008 by the The University of Texas M. D. Anderson Cancer Center indicated that stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumours have more than twice the risk of developing learning and memory problems than those treated with SRS alone. “While both approaches are in practice and both are equally acceptable, data from this study suggest that oncologists should offer SRS alone as the upfront, initial therapy for patients with up to three brain metastases,”[3]

How it works

The fundamental principle of radiosurgery is that of selective ionization of tissue, by means of high-energy beams of radiation. Ionization is the production of ions and free radicals which are usually deleterious to the cells. These ions and radicals, which may be formed from the water in the cell or from the biological materials can produce irreparable damage to DNA, proteins, and lipids, resulting in the cell's death. Thus, biological inactivation is carried out in a volume of tissue to be treated, with a precise destructive effect. The radiation dose is usually measured in grays, where one gray (Gy) is the absorption of one joule per kilogram of mass. A unit that attempts to take into account both the different organs that are irradiated and the type of radiation is the sievert, a unit that describes both the amount of energy deposited and the biological effectiveness.

In order to perform optimal radiosurgery, the radiation oncologist chooses the best type of radiation to be used and how it will be delivered. In order to plan the radiation incidence and dosage, the physicists calculate a map portraying the lines of equal absorbed dose of radiation upon the patient's head (this is called an isodose map). Information about the tumor's location is obtained from a series of computerized tomograms, which are then fed to special planning computer software.

Stereotactic radiosurgery generally utilizes gamma rays and x-rays. There is also increasing interest in using particle therapy such as protons and carbon ions for radiosurgery, though this is not widely available.

The emission head (called "gantry") is mechanically rotated around the patient, in a full or partial circle. The table where the patient is lying, the 'couch', can also be moved in small linear or angular steps. The combination of the movements of the gantry and of the couch makes possible the computerized planning of the volume of brain tissue which is going to be irradiated. Devices with an energy of 6 MeV are the most suitable for the treatment of the brain, due to the depth of the target. In addition, the diameter of the energy beam leaving the emission head can be adjusted to the size of the lesion by means of interchangeable collimators (an orifice with different diameters, varying from 5 to 40 mm, in steps of 5 mm). There are also multileaf collimators, which consist of a number of metal leaflets that can be moved dynamically during treatment in order to shape the radiation beam to conform to the mass to be ablated. Latest generation Linacs are capable of achieving extremely narrow beam geometries, such as 0.15 to 0.3 mm. Therefore, they can be used for several kinds of surgeries which hitherto are carried out by open or endoscopic surgery, such as for trigeminal neuralgia, etc.

Protons, may also be used in radiosurgery Proton Beam Therapy (PBT). Protons are produced by a medical synchrotron, extracting them from proton donor materials and accelerating them in successive travels through a circular, evacuated conduit, using powerful magnets, until they reach sufficient energy (usually about 200 MeV) to enable them to approximately traverse a human body, then stop. They are then released toward the irradiation target which is region in the patient's body. In some machines, which deliver only a certain energy of protons, a custom mask made of plastic will be interposed between the initial beam and the patient, in order to adjust the beam energy for a proper amount of penetration. Because of the Bragg Peak effect, proton therapy has advantages over other the other forms of radiation, since most of the proton's energy is deposited within a limited distance, so tissue beyond this range (and so some extent also tissue inside this range) is spared from the effects of radiation. This property of protons, which has been called the "depth charge effect" allows for conformal dose distributions to be created around even very irregularly shaped targets, and for higher doses to targets surrounded or backstopped by radiation-sensitive structures such as the optic chiasm or brainstem. In recent years, however, "intensity modulated" techniques have allowed for similar conformities to be attained using linear accelerator radiosurgery.

The selection of the proper kind of radiation and device depends on many factors including lesion type, size and location in relation to critical structures. Data suggests that similar clinical outcomes are possible with all of these methods. More important than the device used are issues regarding indications for treatment, total dose delivered, fractionation schedule and conformity of the treatment plan.

Radiosurgery of brain tumors

Radiosurgery has been especially helpful for the localized, highly precise treatment of brain tumors. Due to the steep fall off of the irradiation fields (isodoses) from the center of the target to be ablated, normal structures such as the brain, and other vascular and neural structures around it, are relatively spared. This is achieved through the high mechanical precision of the radiation source, and the assured reproducibility of the target. The precision in the positioning of the patient, in the calculation of dosages, and in the safety of the patient, are all extremely high.

Radiosurgery is indicated primarily for the therapy of tumors, vascular lesions and functional disorders. Significant clinical judgment must be used with this technique and considerations must include lesion type, pathology if available, size, location and age and general health of the patient. General contraindications to radiosurgery include excessively large size of the target lesion or lesions too numerous for practical treatment.

The non-interference with the quality of life of the patient in the post-operatory period competes with the inconvenience of the latency of months until the result of the radiosurgery is accomplished.

Outcome may not be evident for months after the treatment. Since radiosurgery does not remove the tumor, but results in a biological inactivation of the tumor, lack of growth of the lesion is normally considered to be treatment success. General indications for Radiosurgery include many kinds of brain tumors, such as acoustic neuromas, germinomas, meningiomas, metastases , trigeminal neuralgia, arteriovenous malformations and skull base tumors among others. Expansion of stereotactic radiotherapy to extracranial lesions is increasing, and includes metastases, liver cancer, lung cancer, pancreatic cancer, etc. It has been demonstrated by the thousands of successfully treated cases, that radiosurgery can be a very safe and efficient method for the management of many difficult brain lesions, while it avoids the loss in quality of life associated to other more invasive methods.



Capsule Endoscopy

No comments:

Post a Comment